-
Tebideutorexant (developmental code
names JNJ-61393215, JNJ-3215) is an
orexin antagonist medication which is
under development for the
treatment of depression...
- disorder, insomnia, and
sleep apnea, up to
phase 3 – half-life 2–3
hours Tebideutorexant (JNJ-61393215, JNJ-3215) –
selective OX1
antagonist –
under development...
-
Nivasorexant (ACT-539313) RTIOX-276 SB-334867 SB-408124
Suvorexant TCS-1102
Tebideutorexant (JNJ-61393215)
Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19...
-
Nivasorexant (ACT-539313) RTIOX-276 SB-334867 SB-408124
Suvorexant TCS-1102
Tebideutorexant (JNJ-61393215)
Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19...
-
Nivasorexant (ACT-539313) RTIOX-276 SB-334867 SB-408124
Suvorexant TCS-1102
Tebideutorexant (JNJ-61393215)
Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19...
-
Nivasorexant (ACT-539313) RTIOX-276 SB-334867 SB-408124
Suvorexant TCS-1102
Tebideutorexant (JNJ-61393215)
Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19...
-
Nivasorexant (ACT-539313) RTIOX-276 SB-334867 SB-408124
Suvorexant TCS-1102
Tebideutorexant (JNJ-61393215)
Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19...
-
Nivasorexant (ACT-539313) RTIOX-276 SB-334867 SB-408124
Suvorexant TCS-1102
Tebideutorexant (JNJ-61393215)
Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19...
-
Nivasorexant (ACT-539313) RTIOX-276 SB-334867 SB-408124
Suvorexant TCS-1102
Tebideutorexant (JNJ-61393215)
Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19...
-
Nivasorexant (ACT-539313) RTIOX-276 SB-334867 SB-408124
Suvorexant TCS-1102
Tebideutorexant (JNJ-61393215)
Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19...
